These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Thanos PK; Robison LS; Steier J; Hwang YF; Cooper T; Swanson JM; Komatsu DE; Hadjiargyrou M; Volkow ND Pharmacol Biochem Behav; 2015 Apr; 131():143-53. PubMed ID: 25641666 [TBL] [Abstract][Full Text] [Related]
6. Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner. Connor C; Hamilton J; Robison L; Hadjiargyrou M; Komatsu D; Thanos P Curr Pharm Des; 2022; 28(4):331-338. PubMed ID: 33504296 [TBL] [Abstract][Full Text] [Related]
7. Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period. Martin C; Fricke D; Vijayashanthar A; Lowinger C; Koutsomitis D; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Pharmacol Biochem Behav; 2018 Sep; 172():22-32. PubMed ID: 30030127 [TBL] [Abstract][Full Text] [Related]
8. Adolescent social defeat alters N-methyl-D-aspartic acid receptor expression and impairs fear learning in adulthood. Novick AM; Mears M; Forster GL; Lei Y; Tejani-Butt SM; Watt MJ Behav Brain Res; 2016 May; 304():51-9. PubMed ID: 26876136 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain. Richer K; Hamilton J; Delis F; Martin C; Fricke D; Yao R; Sajjad M; Blum K; Hadjiargyrou M; Komatsu D; Thanos PK Brain Res; 2022 Apr; 1780():147799. PubMed ID: 35074404 [TBL] [Abstract][Full Text] [Related]
10. Modification of [3H]MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue: a quantitative autoradiographic study. Giraldez L; Girardi E Neurochem Res; 1998 Oct; 23(10):1327-36. PubMed ID: 9804290 [TBL] [Abstract][Full Text] [Related]
11. Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects. Kalinowski L; Connor C; Somanesan R; Carias E; Richer K; Smith L; Martin C; Mackintosh M; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Dev Psychobiol; 2020 Mar; 62(2):170-180. PubMed ID: 31456229 [TBL] [Abstract][Full Text] [Related]
12. Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain. Tarazi FI; Choi YK; Gardner M; Wong EH; Henry B; Shahid M Synapse; 2009 May; 63(5):413-20. PubMed ID: 19177511 [TBL] [Abstract][Full Text] [Related]
13. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Hussain N; Flumerfelt BA; Rajakumar N Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801. Oh S; Kim YH; Hann HJ; Lee HL; Choi HS; Kim HS; Ho IK Neurochem Res; 2001 May; 26(5):559-65. PubMed ID: 11513485 [TBL] [Abstract][Full Text] [Related]
15. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Gaytan O; Nason R; Alagugurusamy R; Swann A; Dafny N Brain Res Bull; 2000 Apr; 51(6):485-92. PubMed ID: 10758338 [TBL] [Abstract][Full Text] [Related]
16. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex. Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495 [TBL] [Abstract][Full Text] [Related]
18. Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain. Arnavut E; Hamilton J; Yao R; Sajjad M; Hadjiargyrou M; Komatsu D; Thanos PK Synapse; 2022 Aug; 76(9-10):17-30. PubMed ID: 35730134 [TBL] [Abstract][Full Text] [Related]
19. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Yang P; Swann A; Dafny N Physiol Behav; 2000 Oct 1-15; 71(1-2):133-45. PubMed ID: 11134695 [TBL] [Abstract][Full Text] [Related]
20. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Sripada S; Gaytan O; Al-rahim S; Swann A; Dafny N Brain Res; 1998 Dec; 814(1-2):78-85. PubMed ID: 9838055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]